"/> Novus Biologicals™ Peptide bloquant d’anticorps RI… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps RIPK1/RIP1

Réf. : BL-RE-082758Réf. fabricant : 18210086 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
8737
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-77077. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 15 amino acids near the amino terminus of human RIPK1.

Points forts

Source

Synthetic

(Accession #: NP_003795) The RIPK1/RIP1 Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-082758
Réf. fabricant18210086
Gene ID (Entrez)8737
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-77077. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneCell death protein RIP, EC 2.7.11.1, receptor (TNFRSF)-interacting serine-threonine kinase 1, receptor interacting protein, Receptor-interacting protein 1, receptor-interacting serine/threonine-protein kinase 1, RIP1, RIP-1, Rip1 kinase, RIPFLJ39204, Serine/threonine-protein kinase RIP
Symbole de gène(s)RIPK1
Type de produitRIPK1
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne15 amino acids near the amino terminus of human RIPK1
Une question, une configuration particulière ?
Contactez-nous pour un devis.